Publications by the researcher in collaboration with AMAIA ESQUISÁBEL ALEGRÍA (42)

2020

  1. iPSC-Derived Intestinal Organoids from Cystic Fibrosis Patients Acquire CFTR Activity upon TALEN-Mediated Repair of the p.F508del Mutation

    Molecular Therapy - Methods and Clinical Development, Vol. 17, pp. 858-870

2019

  1. Safety and effectiveness of sodium colistimethate-loaded nanostructured lipid carriers (SCM-NLC) against P. aeruginosa: in vitro and in vivo studies following pulmonary and intramuscular administration

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 18, pp. 101-111

2018

  1. Kosmetika onkologikoa: kimioterapiak eta erradioterapiak larruazalean eragindako efektu desiragaitzak eta horiek tratatzeko konposatu naturaletan oinarritutako formulazio berriak

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 33, pp. 35-53

2017

  1. Benznidazole nanoformulates: A chance to improve therapeutics for Chagas disease

    American Journal of Tropical Medicine and Hygiene, Vol. 97, Núm. 5, pp. 1469-1476

2016

  1. Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients

    Journal of Cystic Fibrosis, Vol. 15, Núm. 5, pp. 611-618

  2. Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis

    International Journal of Pharmaceutics, Vol. 498, Núm. 1-2, pp. 263-273

  3. Stability study of sodium colistimethate-loaded lipid nanoparticles

    Journal of Microencapsulation, Vol. 33, Núm. 7, pp. 636-645

  4. The use of nanoparticles for antimicrobial delivery

    New Weapons to Control Bacterial Growth (Springer International Publishing), pp. 453-487

2015

  1. Pulmonary drug delivery: A review on nanocarriers for antibacterial chemotherapy

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 11, pp. 2945-2955

2014

  1. Cellulose acetate phthalate microparticles containing Vibrio cholerae: Steps toward an oral cholera vaccine

    Journal of Drug Targeting, Vol. 22, Núm. 6, pp. 478-487

  2. Repeated dose toxicity study of Vibrio cholerae-loaded gastro-resistant microparticles

    Journal of Microencapsulation, Vol. 31, Núm. 1, pp. 86-92

  3. Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis

    International Journal of Pharmaceutics, Vol. 477, Núm. 1-2, pp. 485-494

2013

  1. An approach to a cold chain free oral cholera vaccine: In vitro and in vivo characterization of Vibrio cholerae gastro-resistant microparticles

    International Journal of Pharmaceutics, Vol. 448, Núm. 1, pp. 247-258

  2. Biomedical applications of immobilized enzymes: An update

    Methods in Molecular Biology, Vol. 1051, pp. 285-299

  3. The state-of-the-art of approved and under-development cholera vaccines

    Vaccine, Vol. 31, Núm. 38, pp. 4069-4078

2011

  1. A new oral vaccine candidate based on the microencapsulation by spray-drying of inactivated Vibrio cholerae

    Vaccine, Vol. 29, Núm. 34, pp. 5758-5764

2007

  1. Proceedings del VIII Congreso de la Sociedad Española de Farmacia Industrial yGalénica

    Leioa : Universidad del País Vasco. Servicio Editorial = Euskal Herriko Unibertsitatea. Argitalpen Zerbitzua, 2007

2002

  1. Preparation and stability of agarose microcapsules containing BCG

    Journal of Microencapsulation, Vol. 19, Núm. 2, pp. 237-244

2000

  1. Effect of aging on the release of salbutamol sulfate from lipid matrices

    Spanish-Portuguese Conference on Controlled Drug Delivery (4º. Vitoria-Gasteiz. 2000)

  2. Effect of lecithins on BCG-alginate-PLL microcapsule particle size and stability upon storage

    Journal of Microencapsulation, Vol. 17, Núm. 3, pp. 363-372